Takeover Panel Act definition
Examples of Takeover Panel Act in a sentence
Any holder of 1% or more of any class of relevant securities of Elan or of Royalty Pharma may have disclosure obligations under Rule 8.3 of the Irish Takeover Panel Act, 1997, Takeover Rules 2007 (as amended).
A transaction in which a third party seeks to acquire 30% or more of our voting rights will be governed by the Irish Takeover Panel Act 1997 and the Irish Takeover Rules made thereunder and will be regulated by the Irish Takeover Panel.
A public-to-private transaction is regulated by the provisions of the Irish Takeover Panel Act 1997 (as amended), the Irish Takeover Rules 2013 (Rules) and the European Communities (Takeover Bids (Directive 2004/25/EC)) Regulations 2006.
In addition, the Irish Takeover Panel Act, 1997, Substantial Acquisition Rules, 2007 came into effect on 19 December 2007.
The following appendices do not form part of the audited financial statementsAppendix 1 Administrative Appendix Relevant Companies The Irish Takeover Panel, established pursuant to the Irish Takeover Panel Act, 1997 (the “Act”), is the body responsible for monitoring and supervising takeovers and other relevant transactions in relation to securities in relevant companies in Ireland.
The Irish Takeover Panel Act, 1997, Takeover Rules, 2013 came into effect on 6 January 2014.
Public takeovers in Ireland are regulated by the Irish Takeover Panel Act 1997, which established the Irish Takeover Panel (the Panel), the Irish Takeover Rules (the Takeover Rules) and the European Communities (Takeover Bids (Directive 2004/25/EC)) Regulations 2006.
If the Administrative Agent so requires and as the Administrative Agent may direct, RPIFT will cause BidCo, at the cost of BidCo, to resist or assist in resisting any challenge by way of judicial review pursuant to Section 13 of the Irish Takeover Panel Act 2007 of any decision, ruling or direction of the Panel if the effect of such challenge would be to render any condition of the Offer unavailable or to prevent any condition of the Offer being invoked by BidCo.
To the best of the knowledge and belief of the directors of Allergan (who have taken all reasonable care to ensure that such is the case), the information contained in this press release is in accordance with the facts and does not omit anything likely to affect the import of such information.Any holder of 1% or more of any class of relevant securities of Allergan may have disclosure obligations under Rule 8.3 of the Irish Takeover Panel Act, 1997, Takeover Rules 2013.
Any person who is the holder of one per cent or more of ARCON Shares may have disclosure obligations under Rule 8.3 of the Irish Takeover Panel Act, 1997, Takeover (Amendment) Rules 2002, effective from the commencement of the offer period in respect of the Merger Offer.